Skip to main content
. 2024 Jul 9;12(7):e01432. doi: 10.1002/rcr2.1432

FIGURE 2.

FIGURE 2

Clinical course of NTM‐PD and ABPA in the present patient. ABPA, allergic bronchopulmonary aspergillosis; ICS/LABA, inhaled corticosteroid/long‐acting β2‐agonist; ICS/LABA/LAMA, inhaled corticosteroid/long‐acting β2‐agonist/long‐acting muscarinic antagonist; IgE, immunoglobulin E; NTM‐PD, nontuberculous mycobacterial‐pulmonary disease.